Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer
The occurrence of markedly accelerated tumor growth during immunotherapy is considered a new mode of progression called hyperprogressive disease (HPD) and its impact on pancreatic cancer (PC) patients receiving immunotherapy is unknown. In this study, we described and explored the incidence, prognos...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2023-08-01
|
| Col·lecció: | Human Vaccines & Immunotherapeutics |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/21645515.2023.2252692 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|